Biobank For MS And Other Demyelinating Diseases
What it found
No result yet.
Who could take part
Early (CIS/RIS)
Inclusion Criteria: * age 18+ able to give informed consent or individuals younger than 18 with parental permission and able to give assent * willing to provide up to 110 ml (50 ml for \< 18 years old) of blood via venipuncture * experienced at least one CNS demyelinating event characteristic of MS, TM, NMO, ADEM, or ON Exclusion Criteria: * history of blood borne pathogens * allogeneic bone marrow transplant * clinical or radiological evidence of stroke, meningitis, or other well characterized diseases of the nervous system (with the exception of MS, TM, NMO, ADEM, or ON). * weight less than 37 pounds
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.
Loading reviews and guidelines…
History
Started
May 2006
Main results due
Oct 2030
Finished
Oct 2036
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error